We are live on ! Find out more
AEPBI

AH Equity Partners Bio III Portfolio holdings

AUM $95M
1-Year Est. Return 50.1%
This Fund
S&P 500
This Quarter Est. Return
+13.56%
1 Year Est. Return
-50.1%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90M
AUM Growth
+$10.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$90M 100%
19,192,015
– –

Similar funds

SC
Sarissa Consulting Santa Monica, California $96.9M AUM 29.32% 1-Year Est. Return
SCA
Spearhead Capital Advisors Wellington, Florida $92.3M AUM 18.16% 1-Year Est. Return
WIM
Wilen Investment Management Bonita Springs, Florida $98.1M AUM 2.08% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM
AAM
Artha Asset Management Hoboken, New Jersey $90.3M AUM 27.65% 1-Year Est. Return
MW
Milestone Wealth Buffalo, New York $89.5M AUM 17.2% 1-Year Est. Return
NIM
NuWave Investment Management Parsippany, New Jersey $87.2M AUM 38.54% 1-Year Est. Return
EFEM
Eos Focused Equity Management New York $84.5M AUM 17.48% 1-Year Est. Return

AH Equity Partners Bio III's Q2 2022 Portfolio in Review

As of Q2 2022, AH Equity Partners Bio III held 1 position worth $90M, up 14% from $79.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. AH Equity Partners Bio III opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AH Equity Partners Bio III's ten largest holdings make up 100% of its $90M portfolio in Q2 2022.
  • AH Equity Partners Bio III opened 0 new positions and closed 0 in Q2 2022.
  • AH Equity Partners Bio III's portfolio value rose 14% quarter-over-quarter to $90M.

Based on AH Equity Partners Bio III's 13F filing for Q2 2022, filed 15 Aug 2022.